Chase Pharmaceuticals Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1B

Chase Pharmaceuticals General Information

Description

Provider of medications for the treatment of neurological and psychiatric diseases. The company focuses on the development of medications for the treatment of Alzheimer's disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1825 K Street
  • Northwest Suite 510
  • Washington, DC 20006
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 1825 K Street
  • Northwest Suite 510
  • Washington, DC 20006
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chase Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 22-Nov-2016 $1B Completed Clinical Trials - Phase 2
5. Later Stage VC (Series B1) 01-Jan-2017 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 16-Mar-2016 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B1) 16-Feb-2016 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 16-Dec-2011 $500K $1.7M Completed Startup
1. Early Stage VC (Series A) 15-Dec-2010 $1.2M $1.2M Completed Startup
To view Chase Pharmaceuticals’s complete valuation and funding history, request access »

Chase Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series A 1,200,000 $0.000100 8% $1 $1 1x $1 6.86%
To view Chase Pharmaceuticals’s complete cap table history, request access »

Chase Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of medications for the treatment of neurological and psychiatric diseases. The company focuses on the developme
Drug Discovery
Washington, DC
11 As of 2016

Clarksville, MD
 

Brighton, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Chase Pharmaceuticals Competitors (76)

One of Chase Pharmaceuticals’s 76 competitors is NeuroNascent, a Venture Capital-Backed company based in Clarksville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD
Enterprise Therapeutics Venture Capital-Backed Brighton, United Kingdom
Asceneuron Venture Capital-Backed Eysins, Switzerland
Minerva Neurosciences Formerly VC-backed Burlington, MA
Alzprotect Venture Capital-Backed Loos, France
You’re viewing 5 of 76 competitors. Get the full list »

Chase Pharmaceuticals Patents

Chase Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3532060-A1 Memantine combinations and use Inactive 28-Oct-2016
EP-3532060-A4 Memantine combinations and use Inactive 28-Oct-2016
US-10548855-B2 Memantine combinations and use Inactive 28-Oct-2016
US-20180116979-A1 Memantine combinations and use Active 28-Oct-2016
US-20190269627-A1 Memantine combinations and use Inactive 28-Oct-2016 A61K31/13
To view Chase Pharmaceuticals’s complete patent history, request access »

Chase Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chase Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority
Brain Trust Accelerator Fund Venture Capital Minority
Cipla New Ventures Impact Investing Minority
New Rhein Healthcare Venture Capital Minority
Revolution (Washington DC) Venture Capital Minority
To view Chase Pharmaceuticals’s complete investors history, request access »

Chase Pharmaceuticals FAQs

  • When was Chase Pharmaceuticals founded?

    Chase Pharmaceuticals was founded in 2007.

  • Where is Chase Pharmaceuticals headquartered?

    Chase Pharmaceuticals is headquartered in Washington, DC.

  • What is the size of Chase Pharmaceuticals?

    Chase Pharmaceuticals has 11 total employees.

  • What industry is Chase Pharmaceuticals in?

    Chase Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Chase Pharmaceuticals a private or public company?

    Chase Pharmaceuticals is a Private company.

  • What is the current valuation of Chase Pharmaceuticals?

    The current valuation of Chase Pharmaceuticals is .

  • What is Chase Pharmaceuticals’s current revenue?

    The current revenue for Chase Pharmaceuticals is .

  • How much funding has Chase Pharmaceuticals raised over time?

    Chase Pharmaceuticals has raised $38.2M.

  • Who are Chase Pharmaceuticals’s investors?

    Andera Partners, Brain Trust Accelerator Fund, Cipla New Ventures, New Rhein Healthcare, and Revolution (Washington DC) have invested in Chase Pharmaceuticals.

  • Who are Chase Pharmaceuticals’s competitors?

    NeuroNascent, Enterprise Therapeutics, Asceneuron, Minerva Neurosciences, and Alzprotect are some of the 76 competitors of Chase Pharmaceuticals.

  • When was Chase Pharmaceuticals acquired?

    Chase Pharmaceuticals was acquired on 22-Nov-2016.

  • Who acquired Chase Pharmaceuticals?

    Chase Pharmaceuticals was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process